{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:02:30Z","timestamp":1789642950230,"version":"4.0.0"},"reference-count":83,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"State Key Laboratory of Drug Regulatory Science Foundation","award":["2025SKLDRS0362"],"award-info":[{"award-number":["2025SKLDRS0362"]}]},{"name":"State Key Laboratory of Drug Regulatory Science Foundation","award":["2025SKLDRS0360"],"award-info":[{"award-number":["2025SKLDRS0360"]}]},{"name":"State Key Laboratory of Drug Regulatory Science Foundation","award":["2026SKLDRS03090"],"award-info":[{"award-number":["2026SKLDRS03090"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/14760584.2026.2734669","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:14:09Z","timestamp":1789640049000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Progress and challenges of biological reference standards for vaccine quality control and evaluation"],"prefix":"10.1080","volume":"25","author":[{"given":"Xuanxuan","family":"Zhang","sequence":"first","affiliation":[{"name":"NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Research Units of Innovative Vaccine Quality Evaluation and Standardization, Chinese Academy of Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Wang","sequence":"additional","affiliation":[{"name":"NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Research Units of Innovative Vaccine Quality Evaluation and Standardization, Chinese Academy of Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Gao","sequence":"additional","affiliation":[{"name":"NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Research Units of Innovative Vaccine Quality Evaluation and Standardization, Chinese Academy of Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"He","sequence":"additional","affiliation":[{"name":"NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Research Units of Innovative Vaccine Quality Evaluation and Standardization, Chinese Academy of Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenglun","family":"Liang","sequence":"additional","affiliation":[{"name":"NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Research Units of Innovative Vaccine Quality Evaluation and Standardization, Chinese Academy of Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Wu","sequence":"additional","affiliation":[{"name":"NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Research Units of Innovative Vaccine Quality Evaluation and Standardization, Chinese Academy of Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunying","family":"Mao","sequence":"additional","affiliation":[{"name":"NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Research Units of Innovative Vaccine Quality Evaluation and Standardization, Chinese Academy of Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"e_1_3_7_2_1","unstructured":"World Health Organization. Recommendations for the preparation characterization establishment and use of WHO international biological reference standards. Replacement of annex 2 of WHO technical report series No. 932. 2026 [cited 2026 Jul 20]. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/biologicals\/who-ibrs-recommendations-final-19-may.pdf?sfvrsn=3d40688c_3&download=true"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2024.101756"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2024.12.011"},{"key":"e_1_3_7_5_1","unstructured":"World Health Organization. Report on the WHO collaborative study to establish the 1st international standard for antibodies to the influenza virus group I haemagglutinin stem domain. [cited 2026 Jan 28]. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/biologicals\/public-consultation\/first-who-is-for-antibody-to-the-influenza-virus-haemagglutinin-stem-domain.pdf?sfvrsn=3df431cf_1"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2025.2475822"},{"key":"e_1_3_7_7_1","unstructured":"Identity and purity analysis of USP cross-reacting material 197 (CRM197) reference standard. [cited 2026 Feb 9]. Available from: https:\/\/www.usp.org\/sites\/default\/files\/usp\/document\/our-work\/biologics\/app-notes\/crm197-tech-note.pdf"},{"key":"e_1_3_7_8_1","unstructured":"World Health Organization. Guidelines on the replacement or removal of animal tests for the quality control of biological products. [cited 2026 Jan 27]. Available from: https:\/\/www.who.int\/publications\/m\/item\/guidelines-on-replacement-of-animal-tests-for-quality-control"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.15217"},{"key":"e_1_3_7_10_1","unstructured":"World Health Organization. WHO manual for the preparation of reference materials for use as secondary standards in antibody testing. Trs 1043 annex 2. 2022 [cited 2026 Feb 25]. Available from: https:\/\/www.who.int\/publications\/m\/item\/who-manual-for-reference-material-for-antibody-testing-annex-2"},{"key":"e_1_3_7_11_1","unstructured":"World Health Organization. WHO manual for the establishment of national and other secondary standards for vaccines. [cited 2026 Jan 27]. Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-IVB-11.03"},{"key":"e_1_3_7_12_1","unstructured":"World Health Organization. WHO manual for the preparation of secondary reference materials for in vitro diagnostic assays designed for infectious disease nucleic acid or antigen detection: calibration to WHO international standards. [cited 2026 Feb 24]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241210133"},{"key":"e_1_3_7_13_1","unstructured":"Ich Q6B specifications: test procedures and acceptance criteria for biotechnological\/biological products - scientific guideline. [cited 2026 Feb 9]. Available from: https:\/\/www.ema.europa.eu\/en\/ich-q6b-specifications-test-procedures-acceptance-criteria-biotechnological-biological-products-scientific-guideline"},{"key":"e_1_3_7_14_1","unstructured":"World Health Organization. Recommendations for the preparation characterization and establishment of international and other biological reference standards annex 2 trs No 932. [cited 2026 Jul 20]. Available from: https:\/\/www.who.int\/publications\/m\/item\/annex2-trs932"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-019-0135-3"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2016.04.006"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00372-08"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2164140"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2023.101679"},{"key":"e_1_3_7_20_1","first-page":"15","article-title":"Establishment of a biological reference preparation for hepatitis a vaccine (inactivated, non-adsorbed)","volume":"1","author":"Stalder J","year":"2010","unstructured":"Stalder J, Costanzo A, Daas A, et al. Establishment of a biological reference preparation for hepatitis a vaccine (inactivated, non-adsorbed). Pharmeur Bio Sci Notes. 2010;1:15\u201329.","journal-title":"Pharmeur Bio Sci Notes"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.10.087"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.19778\/j.chp.2025.01.014"},{"key":"e_1_3_7_23_1","volume-title":"The preparation and establishment of national biological reference standards, Chinese pharmacopoeia","author":"Commission CP","year":"2025","unstructured":"Commission CP. The preparation and establishment of national biological reference standards, Chinese pharmacopoeia. 2025 ed. Beijing, China: China Medical Science and Technology Press; 2025.","edition":"2025"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/1935472X261451580"},{"key":"e_1_3_7_25_1","unstructured":"World Health Organization. Establishment of the 2nd WHO international standard for anti-SARS-CoV-2 immunoglobulin and reference panel for antibodies to SARS-CoV-2 variants of concern. 2022 [cited 2026 Feb 24]. Available from: https:\/\/www.who.int\/publications\/m\/item\/who-bs-2022.2427"},{"key":"e_1_3_7_26_1","unstructured":"World Health Organization. Collaborative study for the establishment of a WHO international standard for SARS-CoV-2 RNA. 2020 [cited 2026 Jan 27]. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/biologicals\/ecbs\/bs-2020-2402-sars-cov-2-rna-17-nov-2020.pdf?sfvrsn=1f6e6d86_2&download=true"},{"key":"e_1_3_7_27_1","unstructured":"World Health Organization. A collaborative study to evaluate the proposed 1st WHO international standard for SARS-CoV-2 antigen. 2022 [cited 2026 Jan 26]. Available from: https:\/\/www.who.int\/publications\/m\/item\/who-bs-2022.2426"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(23)00258-6"},{"key":"e_1_3_7_29_1","unstructured":"World Health Organization. Evaluation of candidate international standards for meningococcal capsular group W and Y polysaccharides. [cited 2026 Jan 27]. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/biologicals\/ecbs\/reference-materials\/bs-2019-2374-menwy-resorcinol-proposal-final.pdf?sfvrsn=aedc9bb4_2&download=true"},{"key":"e_1_3_7_30_1","unstructured":"World Health Organization. Proposed WHO international reference reagent for messenger RNA lipid nanoparticles in trs 1048. [cited 2026 Jan 28]. Available from: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/38dc9ef2-1059-4d24-a260-3ab1b560c046\/content"},{"key":"e_1_3_7_31_1","unstructured":"World Health Organization. Report on the WHO collaborative study to establish the 1st international standard for enterovirus A71 inactivated vaccine. [cited 2026 Jan 26]. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/biologicals\/ecbs\/reference-materials\/bs-2019-2362-ev71-vaccine-ecbs-v8-final.pdf?sfvrsn=4b04ad92_2&download=true"},{"key":"e_1_3_7_32_1","unstructured":"World Health Organization. Establishment of 1st WHO international standard for anti-MERS-CoV antibody. [cited 2026 Jan 26]. Available from: https:\/\/www.who.int\/docs\/default-source\/biologicals\/ecbs\/reference-materials\/2020\/bs-2020-2398-1st-who-is-merscov-ab-ecbs-2020-mattiuzzo-nibsc.pdf"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.05.047"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.3390\/v16040554"},{"key":"e_1_3_7_35_1","unstructured":"Vero cell DNA quantitative national standard for qPCR method 250021. [cited 2026 Feb 24]. Available from: http:\/\/aoc.nifdc.org.cn\/sell\/home\/search.html\/0"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.13200\/j.cnki.cjb.003174"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.13200\/j.cnki.cjb.003149"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.13200\/j.cnki.cjb.004604"},{"key":"e_1_3_7_39_1","unstructured":"National drug reference standards. [cited 2026 Feb 24]. Available from: http:\/\/aoc.nifdc.org.cn\/sell\/home\/search.html"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1673-713X.2022.04.008"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.13200\/j.cnki.cjb.003986"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.02.048"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.13200\/j.cnki.cjb.003587"},{"key":"e_1_3_7_44_1","doi-asserted-by":"publisher","DOI":"10.13200\/j.cnki.cjb.003146"},{"issue":"5","key":"e_1_3_7_45_1","first-page":"445","article-title":"Establishment of three national reference standards for pneumococcal polysaccharides of different serotypes","volume":"17","author":"Wang S","year":"2022","unstructured":"Wang S, Chen Q, Xu M, et al. Establishment of three national reference standards for pneumococcal polysaccharides of different serotypes. Chin Med Biotechnol. 2022;17(5):445\u2013448.","journal-title":"Chin Med Biotechnol"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.13309\/j.cnki.pmi.2022.06.001"},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242115705"},{"key":"e_1_3_7_48_1","unstructured":"Molar mass standards for polysaccharide vaccine characterization. [cited 2026 Mar 17]. Available from: https:\/\/www.usp.org\/biologics\/vaccine-standards\/molar-mass-polysaccharide-vaccines"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.04.053"},{"key":"e_1_3_7_50_1","unstructured":"Fluc mRNA guidance document NIST research-grade test material 10202. [cited 2026 Jan 28]. Available from: https:\/\/tsapps.nist.gov\/srmext\/certificates\/10202.pdf"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.03.085"},{"key":"e_1_3_7_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.02.009"},{"key":"e_1_3_7_53_1","unstructured":"World Health Organization. Establishment of the WHO international standard and reference panel for anti-SARS-CoV-2 antibody. 2020 [cited 2026 Jan 27]. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/biologicals\/ecbs\/bs-2020-2403-sars-cov-2-ab-ik-17-nov-2020_4ef4fdae-e1ce-4ba7-b21a-d725c68b152b.pdf?sfvrsn=662b46ae_8&download=true"},{"key":"e_1_3_7_54_1","volume-title":"Evaluation of commutability of processed samples; approved guideline","author":"Clinical and Laboratory Standards Institute","year":"2014","unstructured":"Clinical and Laboratory Standards Institute. Evaluation of commutability of processed samples; approved guideline. 3rd ed. Malvern, Pennsylania, USA: EPl4-A3, CLSI; 2014.","edition":"3"},{"key":"e_1_3_7_55_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1190404"},{"key":"e_1_3_7_56_1","unstructured":"World Health Organization Expert Committee on Biological Standardization. WHO technical report series No. 626 twenty-ninth report. Geneva World Health Organ. 1978."},{"key":"e_1_3_7_57_1","unstructured":"World Health Organization. Expansion of WHO reference panel for antibodies to SARS-CoV-2 variants of concern. WHO\/BS\/2023.2450. 2023 [cited 2026 Feb 24]. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/biologicals\/bs-documents-(ecbs)\/bs-documents_march-2023\/bs-2450-mattiuzzog_expansion_irp_sars-cov2voc_final0208.pdf?sfvrsn=110e12f4_1&download=true"},{"key":"e_1_3_7_58_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1107639"},{"key":"e_1_3_7_59_1","unstructured":"World Health Organization. Establishment of the first WHO international standard and reference panel for anti-Lassa fever virus antibody. 2021 [cited 2026 Jan 28]. Available from: https:\/\/www.who.int\/publications\/m\/item\/WHO-BS-2021.2406"},{"key":"e_1_3_7_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2011.09.007"},{"key":"e_1_3_7_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2020.01.006"},{"key":"e_1_3_7_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2013.08.001"},{"key":"e_1_3_7_63_1","unstructured":"World Health Organization. Report on the WHO collaborative study to establish the 1st international standard for anti-EV-D68 serum (human). 2022 [cited 2026 Jan 26]. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/biologicals\/bs-documents-(ecbs)\/2022-documents\/who_bs_2022.2418_evd68_serumis.pdf?sfvrsn=4aecad5d_6&download=true"},{"key":"e_1_3_7_64_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2018.297655"},{"key":"e_1_3_7_65_1","unstructured":"World Health Organization. Report on a collaborative study for the proposed WHO 1st international reference panel (19\/158) for the quantitation of lentiviral vector integration copy numbers. 2019 [cited 2026 Jan 27]. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/biologicals\/ecbs\/reference-materials\/bs-2019-2373-lentiviral-vector-is-study-report-final.pdf?sfvrsn=e9d569d8_2&download=true"},{"key":"e_1_3_7_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2025.101472"},{"key":"e_1_3_7_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79698-w"},{"key":"e_1_3_7_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-019-0072-9"},{"key":"e_1_3_7_69_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2023.169"},{"key":"e_1_3_7_70_1","unstructured":"World Health Organization. Report on a collaborative study for proposed 1st international standard for adalimumab. 2019 [cited 2026 Jan 27]. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/biologicals\/ecbs\/reference-materials\/bs-2019-2365-adalimumab-final_ea03443e-cffb-4947-913d-442136b4277e.pdf?sfvrsn=75edb0d8_4&download=true"},{"key":"e_1_3_7_71_1","unstructured":"World Health Organization. WHO international collaborative study of the proposed 1st international standard for Bevacizumab. 2020 [cited 2026 Jan 26].Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/biologicals\/ecbs\/reference-materials\/2020\/bs-2020-2391-1st-is-bevaciazumab-ecbs-2020-jia-nibsc.pdf?sfvrsn=c0b590f4_2&download=true"},{"key":"e_1_3_7_72_1","unstructured":"World Health Organization. Report on a collaborative study for proposed candidate 1st international standard for the biological activities of trastuzumab. 2020 [cited 2026 Jan 26]. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/biologicals\/ecbs\/reference-materials\/2020\/bs-2020-2401-trastuzumab-is-dec-2020-corrected.pdf?sfvrsn=fa8bbf9f_2&download=true"},{"key":"e_1_3_7_73_1","unstructured":"World Health Organization. Proposed 1st WHO international reference panel for infliximab anti-drug antibodies. 2022 [cited 2026 Jan 27]. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/biologicals\/bs-documents-(ecbs)\/2022-documents\/new-2022-document-susan\/bs-2022.2430_wadha--meenu_who-int-ref-panel-for-infliximab-anti-drug-antibodies.pdf?sfvrsn=5ffa6970_1&download=true"},{"key":"e_1_3_7_74_1","unstructured":"World Health Organization. Report on a collaborative study for proposed 1st WHO international standard for Golimumab. 2024 [cited 2026 Jan 27]. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/biologicals\/call-for-comments\/who_bs_2024_2467_golimumab-2024revised20dec.pdf?sfvrsn=f5faacab_1"},{"key":"e_1_3_7_75_1","unstructured":"World Health Organization. Report on a collaborative study for proposed candidate 1st international standard for the biological activities of Cetuximab. 2022 [cited 2026 Jan 28]. Available from: https:\/\/www.who.int\/publications\/m\/item\/who-bs-2022.2429-rev"},{"key":"e_1_3_7_76_1","unstructured":"World Health Organization. Report on a collaborative study for proposed 1st WHO international standard for ranibizumab. [cited 2026 Jan 27]. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/biologicals\/public-consultation\/first-who-international-standard-for-ranibizumab.pdf?sfvrsn=77d8a71c_3"},{"key":"e_1_3_7_77_1","unstructured":"Mire-Sluis A Ritter N Cherney B et al. Reference standards for therapeutic proteins: current regulatory and scientific best practices. 2014 [cited 2026 Feb 24]. Available from: https:\/\/www.bioprocessintl.com\/assays\/reference-standards-for-therapeutic-proteins-current-regulatory-and-scientific-best-practices"},{"key":"e_1_3_7_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2024.09.013"},{"key":"e_1_3_7_79_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2017.277558"},{"key":"e_1_3_7_80_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2017.277525"},{"key":"e_1_3_7_81_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2017.277541"},{"key":"e_1_3_7_82_1","volume-title":"Characterization and qualification of commutable reference materials for laboratory medicine; approved guideline","author":"Clinical and Laboratory Standards Institute","year":"2010","unstructured":"Clinical and Laboratory Standards Institute. Characterization and qualification of commutable reference materials for laboratory medicine; approved guideline. Wayne, PA, USA: EP30-A, CLSI; 2010."},{"key":"e_1_3_7_83_1","first-page":"99","article-title":"Establishment of the Ph. Eur. erythropoietin chemical reference substance batch 1","volume":"2015","author":"Burns C","year":"2015","unstructured":"Burns C, Bristow AF, Buchheit KH, et al. Establishment of the Ph. Eur. erythropoietin chemical reference substance batch 1. Pharmeur Bio Sci Notes. 2015;2015:99\u2013117.","journal-title":"Pharmeur Bio Sci Notes"},{"key":"e_1_3_7_84_1","first-page":"37","article-title":"Collaborative study for the establishment of human immunoglobulin BRP replacement batches","volume":"2018","author":"Karra D","year":"2018","unstructured":"Karra D, Regourd E, Costanzo A. Collaborative study for the establishment of human immunoglobulin BRP replacement batches. Pharmeur Bio Sci Notes. 2018;2018:37\u201361.","journal-title":"Pharmeur Bio Sci Notes"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2026.2734669","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14760584.2026.2734669","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2026.2734669","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:14:31Z","timestamp":1789640071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2026.2734669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":83,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/14760584.2026.2734669"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2026.2734669","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-04-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2734669"}}